Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Business News / Female-libido enhancer Addyi's maker sold for $1 billion
  • Business

    Female-libido enhancer Addyi's maker sold for $1 billion

    Vaneet Randhawa
    Written by
    Vaneet Randhawa
    Mail
    Last updated on Aug 21, 2015, 07:26 pm
    Female-libido enhancer Addyi's maker sold for $1 billion
  • The Wall Street Journal reported that Valeant Pharmaceuticals International, Inc will buy Raleigh-based Sprout Pharmaceuticals for approximately $1 billion.

    Interestingly, this acquisition comes before the expected sale of female libido enhancer Addyi from 17 October 2015, which had been created by Sprout Pharmaceuticals.

    Valeant is planning to keep Sprout's leadership team unchanged and maintain its offices in Raleigh.

  • In this article
    Valeant's push-start to become biggest pharma company World famous Wellbutrin antidepressant- a Valeant product Bausch & Lomb acquired by Valeant Allergan slips out of Valeant's fingers Allergan's CEO explains why Valiant deal failed On to the stomach-disorders treatment market Valiant becomes Canada's largest company Female-libido enhancer Addyi's maker sold for $1 billion What is Addyi?
  • Introduction

    Valeant's push-start to become biggest pharma company

    Valeant's push-start to become biggest pharma company
  • ICN Pharmaceuticals which later became Valeant was formed as a US business by merging of several group units in the 1990s.

    In 2010, Valeant was born out of a merger of its U.S. predecessor and Canada's Biovail Corp.

    Valeant has a portfolio of more than 500 products to its name.

    Since its inception, Valeant has stuck to making multi-billion dollar deals aimed at expansion.

  • Do you know?

    World famous Wellbutrin antidepressant- a Valeant product

  • Valeant's most famous drug is Wellbutrin, an anti-depressant and Kinerase which uses Kinetin as an ingredient and reduces freckles and spots on the skin.

  • 29 May 2013

    Bausch & Lomb acquired by Valeant

    Bausch & Lomb acquired by Valeant
    Credits:
  • Valeant Pharmaceuticals International Inc. acquired Warburg Pincus LLC's eye-care company Bausch & Lomb Holdings Inc for $8.7 billion.

    Of the $8.7 billion, $4.2 billion would be used to pay Bausch & Lomb's debts.

    This deal is Valeant's biggest deal since its creation in 2010.

    With this deal, Valeant will compete in the fast growing, and highly specialized ophthalmology market.

  • 12 May 2014

    Allergan slips out of Valeant's fingers

    Allergan slips out of Valeant's fingers
    Credits:
  • Valeant Pharmaceuticals' $47 billion bid to take over U.S. drugmaker Allergan, mostly known as the creator of Botox failed to follow through.

    Valeant's business model to cut costs was not considered sustainable by Allergen who claimed that the offer was too risky.

    This came after Valeant's April 22 declaration saying it expected Allergan to make at least $2.7 billion in annual cost cuts.

  • Quote

    Allergan's CEO explains why Valiant deal failed

  • "Valeant's model of cutting and slashing really doesn't work for more than a very short period of time," Allergan Chief Executive Officer David Pyott said.

  • 22 Feb 2015

    On to the stomach-disorders treatment market

    On to the stomach-disorders treatment market
  • Valeant Pharmaceuticals International Inc. divulged its plans to buy Salix Pharmaceuticals Ltd. in a $10 billion deal.

    The deal will make Valeant a household name for treatment of stomach disorders like traveller's diarrhoea.

    Valeant's deal hoped to tap the U.S. market for stomach-disorder treatments which is valued at $5 billion and is expected to grow by 5% annually.

  • 23 Jul 2015

    Valiant becomes Canada's largest company

    Valiant becomes Canada's largest company
  • In July 2015, Valeant Pharmaceuticals International Inc. eclipsed the Royal Bank of Canada to become Canada's largest company by market value.

    Valeant shares rose more than 9% to $341.02 per share (its 52 week high) and the company reached a market value of $116.3 billion on the Toronto Stock Exchange.

    The pharmaceutical giant has surged 105% in the current year.

  • 22 Aug 2015

    Female-libido enhancer Addyi's maker sold for $1 billion

    Female-libido enhancer Addyi's maker sold for $1 billion
  • The Wall Street Journal reported that Valeant Pharmaceuticals International, Inc will buy Raleigh-based Sprout Pharmaceuticals for approximately $1 billion.

    Interestingly, this acquisition comes before the expected sale of female libido enhancer Addyi from 17 October 2015, which had been created by Sprout Pharmaceuticals.

    Valeant is planning to keep Sprout's leadership team unchanged and maintain its offices in Raleigh.

  • Information

    What is Addyi?

  • Addyi or what is popularly being termed as a 'female Viagra' is Sprout's latest creation, which has managed to get approval from the Food and Drugs Administration, USA but with 'severe warning'.

Latest News
  • NewsBytes Briefing: Twitter will soon have paywalls, and more
    NewsBytes Briefing: Twitter will soon have paywalls, and more
    Science
  • Volkswagen Virtus spotted in India, testing parts for Vento replacement
    Volkswagen Virtus spotted in India, testing parts for Vento replacement
    Auto
  • Coronavirus: India's tally reaches 11.07 million with 16K+ new cases
    Coronavirus: India's tally reaches 11.07 million with 16K+ new cases
    India
  • 'Mumbai Saga' trailer: A screaming John locks horns with Emraan
    'Mumbai Saga' trailer: A screaming John locks horns with Emraan
    Entertainment
  • Facebook COO Sheryl Sandberg pens 'open love letter' to fiance
    Facebook COO Sheryl Sandberg pens 'open love letter' to fiance
    Entertainment
Related Timelines
  • US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
    US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
    World
Trending Topics
Bharti Airtel Mukesh Ambani Flipkart WhatsApp Reliance Jio OPPO Isha Ambani
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Business news?

Subscribe to stay updated.

Business Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Flipkart Virat Kohli
Rohit Sharma Cricket News YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga Honda Batman
Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota Fashion Tips Farmers Protest
Mercedes Barcelona La Liga Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Bharat Bandh Deadpool
Marvel Comics Avengers Neha Kakkar Premier League
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021